News Screening for gene variants should be broadened to reduce health inequalities, systematic review concludes Study authors have called for an extension to DPYD genetic testing in the UK, to include variants identified in people with African ancestry.…Published: 31 July 2024
News MHRA approves capivasertib for treatment of advanced breast cancer Capivasertib is an oral pill given with fulvestrant, a hormonal therapy, as an alternative treatment to endocrine-based regimens.…Published: 25 July 2024
News Draft NICE guidance recommends ‘at-home’ pill for advance prostate cancer The National institute of Health and Care Excellence says up to 40,000 people in England could benefit from relugolix (Orgovyx; Accord).…Published: 22 July 2024
Feature Medical drone deliveries: a viable option for the NHS? In this episode of The PJ Pod, we speak to experts who are testing the feasibility of using drones to deliver NHS medicines.…Published: 10 July 2024
Feature How AI is transforming drug discovery Pharmaceutical companies and start-ups are harnessing AI to improve speed and reduce costs at every stage of the drug discovery and development process.…Published: 3 July 2024
News Combination treatment before surgery improves melanoma survival rates, study results show The 12-month event-free survival rate for patients with macroscopic stage III node-positive melanoma was 83.7% with the combination treatment, compared with 57.2% for adjuvant therapy alone.…Published: 11 June 2024
News Osimertinib treatment for advanced non-small cell lung cancer increases survival rates, study finds Patients treated with osimertinib had an average of 39.1 months of progression-free survival, compared with 5.6 months in those given placebo.…Published: 5 June 2024
Feature BRUKINSA: a next-generation BTK inhibitor Read more to learn how BRUKINSA could benefit your patients with CLL.…Published: 4 June 2024 Promotional content
Opinion Why we are helping patients with lung cancer symptoms self-refer for a chest X-ray Pharmacies in Leeds are helping to diagnose lung cancer earlier by piloting a service that allows patients with red-flag symptoms to refer themselves to hospital for testing.…Published: 8 May 2024
News More than 60 community pharmacies access cancer red-flag symptom card scheme Exclusive: The ‘Not normal for you?’ scheme enables pharmacists to identify patient behaviours that may signal cancer and refer patients for red-flag symptoms.…Published: 16 April 2024
